Biogen pays California biotech $350M upfront for Alzheimer's gene therapy

Triangle Business Journal

Feb 28, 2020

As the world waits for Biogen to submit what could be the first new Alzheimer's disease drug in several years, the drugmaker, with a large Triangle presence, has struck a deal to d…